falsefalse

Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHD - Episode 8

Future Directions in Chronic GvHD

,

Dr. Chaudhary and Dr. Merin discuss potential areas for exploration and unmet needs in the chronic GvHD treatment landscape.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: The Chronic GvHD Landscape: Risk Factors and Diagnosis
    EP. 2: First-line Treatment for Patients with Chronic GvHD
    EP. 3: Defining and Managing Steroid Refractory Chronic GvHD
    EP. 4: Role of Ruxolitinib in Steroid-Refractory Chronic GvHD
    EP. 5: Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil
    EP. 6: Key Efficacy Data of Ibrutinib and Belumosudil in Steroid-Refractory Chronic GvHD Patients
    EP. 7: Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD
    Now Viewing
    EP. 8: Future Directions in Chronic GvHD

    Related Content:

    Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHDCedars-Sinai CancerUSC Norris Comprehensive Cancer CenterHematologic Oncology
    Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Radiation Oncology and Immune Stimulation
    Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Trial Design and Key Data
    Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Overview of Paradigm
    x